Msn Life Sciences Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is EMPAGLIFLOZIN (AMORPHOUS), with a corresponding US DMF Number 32662.
Remarkably, this DMF maintains an Active status since its submission on May 02, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 27, 2021, and payment made on September 16, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II